Ozurdex, a long-acting intravitreal steroid, delivered via a sustained-release ocular implant is now available and funded for New Zealand adult diabetic macular oedema (DMO) patients, which is welcome news, say Kiwi retina specialists.
Ophthalmology New Zealand (ONZ) has launched a new website as part of its transformation to a more commercial and thus professional umbrella body to better service New Zealand’s ophthalmologists.
J&J Vision (formerly AMO) has appointed Camille Furnandiz as a specialist sales representative for New Zealand, effectively doubling New Zealand’s on the ground surgical sales team.
A new study¹ by the Centre for Public Health at the Queen’s University in Belfast, Northern Ireland, has shown that multicolour imaging has a higher sensitivity for detecting early age-related macular degeneration (AMD) compared to colour fundus photography (CFP).
Following a bit of a backlash from some Kiwi ophthalmologists, aflibercept is back on the government’s Pharmaceutical Management Agency’s (Pharmac’s) funding agenda and has been recommended as the second line anti-VEGF treatment, replacing ranibizumab.
New Zealand medical retina specialist and well-known macular degeneration awareness champion, Dr Dianne Sharp, was awarded the RANZCO Distinguished Service Award at the 49th Congress for her services to ophthalmology and the community.
Eye Institute (EI) celebrated a big milestone in October for founding ophthalmologist Dr Peter Ring, who has helped 46,000 patients, and is still going strong. Dr Ring co-founded EI with Drs Dr Bruce Hadden and Anthony Morris in 1995, was instrumental in bringing intraocular lenses into New Zealand
NovaTears, a new treatment for evaporative dry eye disease (DED) has been launched in New Zealand and Australia.
Macular Degeneration New Zealand (MDNZ) unveiled its vision for 2020 at a cocktail party in October, generously hosted by The Kelliher Charitable Trust in Parnell, Auckland.
eigh Plowman, Australian-based optometrist, blogger and digital marketer was one of the keynote Masterclass speakers at ODMA17, attracting a capacity crowd to his talk, ‘How to get new patients from Facebook’. Independents’ major strength is the trust resulting from the relationship they have with
Kiwi eye health professionals took to the airwaves in October adding their voice to the call for governments on both sides of the ditch to ban eyeball tattooing, following yet another patient horror story. Auckland ophthalmology training registrar Dr Zak Prime and New Zealand Association of Optomet
Eyewear technology company, eSight, has launched its new generation eSight 3 electronic autofocus wearable magnifier in New Zealand and Australia. This hands-free low vision glasses technology aims to help visually-impaired patients see in much the same way as sighted people do, allowing them to car
